ASMB
Assembly Biosciences Inc
NASDAQ: ASMB · HEALTHCARE · BIOTECHNOLOGY
$26.95
+2.35% today
Updated 2026-04-30
Market cap
$442.93M
P/E ratio
—
P/S ratio
6.13x
EPS (TTM)
$-0.55
Dividend yield
—
52W range
$11 – $40
Volume
0.1M
Assembly Biosciences Inc (ASMB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-8.47%
Operating margin
46.60%
ROE
-5.10%
ROA
-4.02%
Debt/equity
0.02x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | — | $-8.79M | — | — | — |
| 2009 | — | $-4.54M | — | — | — |
| 2010 | — | $-15.29M | — | — | — |
| 2011 | $0.00 | $-34.34M | — | — | — |
| 2012 | $0.00 | $-24.79M | — | — | — |
| 2013 | $0.00 | $-19.40M | — | — | — |
| 2014 | $0.00 | $-23.79M | — | — | — |
| 2015 | $0.00 | $-28.45M | — | — | — |
| 2016 | $0.00 | $-44.26M | — | — | — |
| 2017 | $9.02M | $-42.81M | -390.37% | -579.09% | -474.66% |
| 2018 | $14.80M | $-90.75M | -391.36% | -626.42% | -613.02% |
| 2019 | $15.96M | $-97.63M | 100.00% | -643.44% | -611.63% |
| 2020 | $79.11M | $-62.15M | -28.10% | -81.89% | -78.57% |
| 2021 | $6.25M | $-129.85M | 100.00% | -2,121.65% | -2,076.35% |
| 2022 | $0.00 | $-92.07M | — | — | — |
| 2023 | $7.16M | $-61.23M | -582.67% | -902.50% | -854.78% |
| 2024 | $28.52M | $-40.18M | 100.00% | -159.26% | -140.87% |
| 2025 | $72.30M | $-6.12M | 99.82% | -16.76% | -8.47% |